Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Indian journal of tuberculosis
- Publicado em
- 12 mai 2023
- Citações
- 17
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis
Syeda Hoorulain Ahmed, Hoorain Haider, Abdul Moeed, Aysal Mahmood, Nasir Shivani, Syed Hasan Shuja, Javeria Hayat, Bushra Jamil, Razia Fatima
Descritores MeSH
- Diarylquinolines
- Antitubercular Agents
- Nitroimidazoles
- Oxazoles
- Tuberculosis, Multidrug-Resistant
- Adult
- Drug Therapy, Combination
- Humans
- Treatment Outcome
Veja também
Estudos relacionados
- A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
- Chinese guideline for the chemotherapy of multidrug-resistant/rifampicin-resistant tuberculosis (2026 edition)
- Adverse events in bedaquiline- and pretomanid-based regimens for drug-resistant tuberculosis from trial, implementation and pharmacovigilance studies
- Hepatic Safety of Bedaquiline, Delamanid, and Pretomanid: A Systematic Review and Meta-analysis